1. Löffler W. Zur differential-diagnose der lungeninfiltrierungen. Il uber fluchtige succedan-infiltrate (mit eosinophilie). Beitr Klin Tuberk. 1932. 79:368–392.

2. Crofton JW, Livingstone JL, Oswald NC, Roberts AT. Pulmonary eosinophilia. Thorax. 1952. 7:1–35.

3. Reeder WH, Goodrich BE. Pulmonary infiltration with eosinophilia (PIE syndrome). Ann Intern Med. 1952. 36:1217–1240.

4. Cottin V, Cordier J-F. Eosinophilic pneumonias. Allergy. 2005. 60:841–857.

5. Marchand E, Cordier JF. Idiopathic chronic eosinophilic pneumonia. Semin Respir Crit Care Med. 2006. 27:134–141.

6. Thomeer MJ, Costabe U, Rizzato G, Poletti V, Demedts M. Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J Suppl. 2001. 32:114s–118s.

7. Marchand E, Reynaud-Gaubert M, Lauque D, Durieu J, Tonnel AB, Cordier JF. Idiopathic chronic eosinophilic pneumonia. A clinical follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore). 1998. 77:299–312.

8. Jeong YJ, Kim KI, Seo IJ, Lee CH, Lee KN, Kim KN, et al. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics. 2007. 27:617–639.

9. Marchand E, Etienne-Mastroianni B, Chanez P, Lauque D, Leclerc P, Cordier JF. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J. 2003. 22:8–13.

10. Durieu J, Wallaert B, Tonnel AB. Long-term follow-up of pulmonary function in chronic eosinophilic pneumonia. Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J. 1997. 10:286–291.

11. Badesch DB, King TE Jr, Schwarz MI. Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am Rev Respir Dis. 1989. 139:249–252.

12. Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med. 1989. 321:569–574.

13. Philit F, Etienne-Mastroianni B, Parrot A, Guerin C, Robert D, Cordier JF. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med. 2002. 166:1235–1239.

14. Daimon T, Johkoh T, Sumikawa H, Honda O, Fujimoto K, Koga T, et al. Acute eosinophilic pneumonia: thin-section CT findings in 29 patients. Eur J Radiol. 2008. 65:462–467.

15. Rom WN, Weiden M, Garcia R, Yie TA, Vathesatogkit P, Tse DB, et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med. 2002. 166:797–800.

16. Shorr AF, Scoville SL, Cersovsky SB, Shanks GD, Ockenhouse CF, Smoak BL, et al. Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. JAMA. 2004. 292:2997–3005.

17. Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN. Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore). 1996. 75:334–342.

18. Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med. 2006. 27:142–147.

19. Hardy WR, Anderson RE. The hypereosinophilic syndrome. Ann Intern Med. 1968. 68:1220–1229.

20. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic, syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975. 54:1–27.

21. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003. 348:1201–1214.

22. Kilon AD, Robyn J, Akin C, Noel P, Brown M, Law M, et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood. 2004. 103:473–478.

23. Cogan E, Schandené L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med. 1994. 330:535–538.

24. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic and therapeutic considerations. Ann Intern Med. 1982. 97:78–92.

25. Roufosse F, Goldman M, Cogan E. Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants. Semin Respir Crit Care Med. 2006. 27:158–170.

26. Roufosse F, Cogan E, Goldman M. Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy. 2004. 59:673–689.

27. Hinson KF, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax. 1952. 7:317–333.

28. Pepys A. Karger S, editor. Hypersensitivity diseases of the lung due to fungi and organic dusts. Monographs in allergy. 1969. Basel, Switzerland: S. Karger.

29. Tillie-Leblond I, Tonnel AB. Allergic bronchopulmonary aspergillosis. Allergy. 2005. 60:1004–1013.

30. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002. 110:685–692.

31. Proceedings of the Cystic Fibrosis Foundation ABPA consensus conference. 2002. 2001 Jun 12-13; Bethesda, Md. Bethesda, Md: North American Cystic Fibrosis Foundation.

32. Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med. 1982. 96:286–291.

33. Hemmann S, Menz G, Ismail C, Blaser K, Crameri R. Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization. J Allergy Clin Immunol. 1999. 104:601–607.

34. Malo JL, Inouye T, Hawkins R, Simon G, Turner-Warwick M, Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis. 4. Comparison with a group of asthmatics. Thorax. 1977. 32:275–280.

35. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzard A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000. 342:756–762.

36. Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol. 2003. 111:952–957.

37. Hong ST. Gungnae gisaengchung gamnyeomjeungui hyeonhwang. J Korean Med Assoc. 1998. 41:737–745.

38. Chai JY. Food-borne parasitic diseases. J Korean Med Assoc. 2004. 47:496–507.

39. Shin S. Parasitic zoonosis transmitted by pet animals. J Korean Med Assoc. 2004. 47:527–534.

40. Chitkara RK, Krishna G. Parasitic pulmonary eosinophilia. Semin Respir Crit Care Med. 2006. 27:171–184.

41. Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med. 2006. 27:192–197.

42. Kilbourne EM, Rigau-Perez JG, Heath CW Jr. Clinical epidemiology of toxic-oil syndrome. Manfestations of a new illness. N Engl J Med. 1983. 309:1408–1414.

43. Alonso-Ruiz A, Calabozo M, Perez-Ruiz F, Mancebo L. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Medicine Baltimore. 1993. 72:285–295.

44. Silver RM, Heyes MP, Maize JC, Quearry B, Vionnet-Fuasset M, Sternberg EM. Scleroderma, fascities, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med. 1990. 322:874–881.

45. Cottin V, Frognier R, Monnot H. Chronic eosinophilic pneumonia after radiation therapy for breast cancer. Eur Respir J. 2004. 23:9–13.